Eagle Rock Investment Company’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Buy
9,288
+4
+0% +$527 0.15% 89
2026
Q1
$1.29M Hold
9,284
0.19% 87
2025
Q4
$1.14M Sell
9,284
-260
-3% -$31.6K 0.16% 91
2025
Q3
$1.06M Buy
9,544
+260
+3% +$29.6K 0.16% 92
2025
Q2
$1.03M Sell
9,284
-262
-3% -$27.9K 0.16% 91
2025
Q1
$1.07M Sell
9,546
-103
-1% -$10.6K 0.18% 93
2024
Q4
$891K Hold
9,649
0.15% 98
2024
Q3
$809K Sell
9,649
-25
-0.3% -$1.91K 0.14% 103
2024
Q2
$664K Buy
9,674
+67
+0.7% +$4.47K 0.12% 103
2024
Q1
$704K Sell
9,607
-30
-0.3% -$2.31K 0.13% 102
2023
Q4
$781K Buy
9,637
+20
+0.2% +$1.56K 0.16% 95
2023
Q3
$721K Hold
9,617
0.16% 93
2023
Q2
$745K Hold
9,617
0.16% 94
2023
Q1
$798K Hold
9,617
0.18% 91
2022
Q4
$839K Buy
9,617
+26
+0.3% +$2.06K 0.19% 92
2022
Q3
$592K Buy
9,591
+368
+4% +$23.2K 0.15% 93
2022
Q2
$570K Buy
+9,223
New +$571K 0.14% 93

Other funds holding GILD

Eagle Rock Investment Company's GILD Position: Q2 2026 in Review

Eagle Rock Investment Company increased its Gilead Sciences (GILD) stake by 0.04% in Q2 2026, buying an estimated $527 and bringing the position to 9,288 shares worth $1.17M. The position accounts for 0.15% of the portfolio, ranked #89.

Eagle Rock Investment Company first reported a position in GILD in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.29M in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Eagle Rock Investment Company held 9,288 shares of Gilead Sciences worth $1.17M as of Q2 2026.
  • Eagle Rock Investment Company bought 4 Gilead Sciences shares in Q2 2026, an estimated $527.
  • Gilead Sciences made up 0.15% of Eagle Rock Investment Company's portfolio in Q2 2026, its #89 holding.
  • Eagle Rock Investment Company first reported a position in Gilead Sciences in Q2 2022 and has held it in 17 quarters since.
  • Eagle Rock Investment Company's Gilead Sciences position peaked at $1.29M in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Eagle Rock Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.